PLAINVIEW, NY / ACCESSWIRE / January 6, 2016 / Vasomedical, Inc. (“Vasomedical”) (VASO) today announced the appointment of Shawl Lobree as President of Vaso Diagnostics, Inc. d/b/a/ VasoHealthcare, a wholly owned subsidiary of Vasomedical, effective January 1, 2016. VasoHealthcare has since July 1, 2010 been the exclusive representative for the sale of select GE Healthcare...
Read More

PLAINVIEW, NY / ACCESSWIRE / November 16, 2015 / Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO) today announced that it has been named on the Deloitte’s Technology Fast 500(TM) list for the fourth consecutive year. Deloitte’s Technology Fast 500 is a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies...
Read More

Reporting 128% Revenue Growth and Operating Profit of $1.3 Million for the Quarter PLAINVIEW, NY–(Marketwired – Nov 12, 2015) –  Vasomedical, Inc. (“Vasomedical”) (OTC PINK: VASO) today reported its operating results for the three months ended September 30, 2015. “We are very excited to report a 128% year-over-year revenue growth at Vasomedical for the third...
Read More

Management to Hold Investor Conference Call on November 12, 2015 at 2:00 p.m. ET PLAINVIEW, NY / ACCESSWIRE / November 5, 2015 / Vasomedical, Inc. (PINKSHEETS: VASO) announced today that it will release its financial results for the three months ended September 30, 2015 on Thursday, November 12, 2015, before market open. The Company will...
Read More

WESTBURY, NY / ACCESSWIRE / September 25, 2015 / Vasomedical, Inc. (“Vasomedical”) (VASO) today announced the relocation of its corporate office, effective Monday, September 28, 2015, to 137 Commercial Street, Plainview, NY 11803. In addition to the headquarters, this facility at Plainview, Long Island will also house the operations of Vasomedical Solutions, Inc. and the...
Read More